Source: LeanLife Health Inc.
  • LeanLife Health (LLP) has closed a first tranche of a $1M private placement for proceeds of $365,000
  • The company issued a total of 7,300,000 units at a price of $0.05 per unit 
  • The company intends to use the proceeds for general capital purposes & towards the licensing agreement/product purchase orders with Foodcare
  • LeanLife Health offers high-quality omega3 plant-based oils as well as its line of Iron Energy drinks
  • LeanLife Health (LLP) is unchanged on the day, trading at C$0.04 per share at 1 pm EST

LeanLife Health (LLP) has closed a first tranche of it $1 million private placement for proceeds of $365,000.

The company issued a total of 7,300,000 units at a price of $0.05 per unit. 

Each unit consists of of one common share and one-half a transferrable share purchase warrant. Each whole warrant will entitle the holder to purchase an additional share at a price of $0.075 per for a 2-year period.

All the securities issued are subject to a four month statutory hold period.

The warrants are subject to an acceleration clause.

LeanLife will pay finder’s fees totalling $27,000 in cash, and 540,000 in finders warrants. 

The company intends to use the proceeds for general capital purposes & towards the licensing agreement/product purchase orders with Foodcare.

LeanLife Health offers high-quality omega3 plant-based oils as well as its line of Iron Energy drinks.

LeanLife Health (LLP) is unchanged on the day, trading at C$0.04 per share at 1 pm EST.

More From The Market Online

Four of the Magnificent Seven dropped today: Here’s why

The Magnificent Seven generated nearly two-thirds of the S&P 500's returns in 2023 and account for more than 25 per cent of the index.

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.